DAFTAR PUSTAKA

1. Gudjonsson JE, Elder JT. Psoriasis. Dalam: Goldsmith LA, Katz SI,

Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editor. Fitzpatrick’s

dermatology in general medicine. Edisi ke-8. New York: McGraw-Hill;

2012; hal. 197-242.

2. Langley RG, Krueger GG, Griffiths CE. Psoriasis: Epidemiology, clinical

features and quality of life. Ann Rheum Dis 2005;64:8-23.

3. Barker JN. Genetic aspect of psoriasis. Clin and Exp Dermatol

2001;26:321-25.

4. Ghoreschi K, Weigert C, Rocken M. Immunopathogenesis and role of T

cells in psoriasis. Clinics in Dermatology 2007;25: 574–580.

5. Anna B, Nicola B, Matteo M, Maria S, Serena L, Fabio A. Pathogenesis of

psoriasis: the role of pro-inflammatory cytokines produced by

keratinocytes. Dalam: Jennifer Soung, editor. Psoriasis. Edisi ke-2.

Kroatia: 2012;2:9-22.

6. Bernard FX, Morel F, Camus M, Pedretti N, Barrault C, Garnier J.

Keratinocytes under fire of proinflammatory cytokines. Journal of Allergy

2012;12:1-10.

7. Nicolaou A. Eicosanoids in skin inflammation. Journal of Prostaglandins,

leukotrienes and essential fatty acids 2013;88:131-38.

8. Simopoulos A. Omega-3 fatty acids in inflammation and autoimmune

disease. J Am Clin Nutr 2002;21:495-505.

9. Mayser P, Grimm H, Grimmiger F. Omega-3 fatty acids in psoriasis.

British Journal of Nutrition 2002;87:S77-82.

10. Iversen L, Kragballe K. Eicosanoids in inflammatory and immunological

skin disorder. J Am Clin Nutr 2000;21:227-33.

11. Rustan AC, Drevon CA. Fatty acid: structures and properties.

Encyclopedia of Life Sciences 2005:1-7.

12. Simopoulos AP. Omega-6/omega-3 essential fatty acids: biological

effects. Word Rev Nutr Diet 2009;99: 1-16.

13. Calder PC. Polyunsaturated fatty acids and inflammatory processes.

Biochimie. 2009;91:791-95.

14. Patterson E, Wall R, Fitzgerald GF, Ross RP. Health implications of high

dietary omega-6 polyunsaturated fatty acids. Journal of Nutrition and

Metabolism 2012;2:1-16.

15. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio

and genetic variation: nutrional implications for chronic diseases.

Biomedicine & Pharmacotherapy 2006;60:502-507.

16. Candela CG, Lopez B, Kohen VL. Importance of a balanced

omega6/omega3 ratio for the maintenance of health nutritional

recommendations. Nutr Hosp 2011;26:323-329.

17. Simopoulos AP. Omega-6/omega-3 essential fatty acid ratio and chronic

diseases. Food Reviews International 2004;20:77-90.

18. Millsop JW, Bhatia BK, Debbaneh M, Koo J, Liao W. Diet and psoriasis,

part III: role of nutritional supplements. J Am Acad Dermatol

2014;71:561-69.
19. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate

criterion to define severity in chronic plaque-type psoriasis. Clinical and

Laboratory Investigations 2005;210:194-99.

20. Gaspari AA. Innate and adaptive immunity and the patophysiology of

psoriasis. J. Am Acad Dermatol 2006;53: 94-100.

21. De Rie M.A, Goedkoop A.Y, Bos J.D. Overview of psoriasis. Dermatol

Ther 2004;17:341-49.

22. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon

KB. Guidelines of care for the management of psoriasis and psoriatic

arthritis. J Am Acad Dermatol 2009;4: 643-59.

23. Balato A, Balato N, Megna M, Schiattarella M, Lembo S. Pathogenesis of

psoriasis: the role pro-inflammatory cytokines produced by keratinocytes.

Clinics in Dermatology 2009;25: 572–580.

24. Molteni S, Reali E. Biomarkers in the pathogenesis, diagnosis and

treatment of psoriasis. Psoriasis Targets and Therapy 2012;2:55-66.

25. Ghoreschi K, Weigert C, Rocken M. Immunopathogenesis and role of T

cells in psoriasis. Clinics in Dermatology 2007;25: 574–80.

26. Abdelnoor AM. Factors involved in the pathogenesis of psoriasis.

Advanced Studies in Medical Sciences 2013;1: 75-94.

27. Krueger JG. The immunologic basis for the treatment of psoriasis with

new biologic agents. J AM Acad Dermatol 2002;46: 1-23.

28. Darouti ME, Hay RA. Psoriasis: highlights on pathogenesis, adjuvant

therapy and treatment of resistant and problematic cases part 1. J Egypt

Women Dermatol Soc 2010;7:64-70.

29. Davidovici AA, Sattar N, Jong PC. Psoriasis and systemic inflammatory

diseases: potential mechanistic links between skin disease and co-morbid

conditions. Journal of Investigative Dermatology 2010;130:1785-1796.

30. Ashcroft DM, Wan PL, Williams HC, Friffiths CE. Clinical measures of

disease severity and outcome in psoriasis: a critical appraisal of their

quality. Br J Dermatol 1999;141:185-191.

31. Mayes PA. Metabolisme asam lemak tak jenuh dan eikosanoid. Dalam:

Murray RK, Granner DK, Mates PA, Rodwell VW, eds. Biokimia

Harper.Edisi ke- 25. Jakarta:EGC; 2001. H.236-244.

32. Benati B, Peluso G, Nicolai R. Polyunsaturated fatty acids: biochemical,

nutritional and epigenetic properties. Journal of the American College of

Nutrition 2004;23:281-302.

33. Ziboh VA, Miller CC, Cho Y. Metabolism of polyunsaturated fatty acids

by skin epidermal enzymes: generation of anti-inflammatory and

antiproliverative metabolites. Am J Clin Nutr 2000;71:361-366.

34. Proksch E. Biosynthesis of fatty acids in the skin and their role in

epidermal barrier function. Dalam: Schroder M, editor. Fatty acids and

skin diseases. Edisi ke-4. Switzerland; 2000:1-11.

35. Fogh K, Kragballe K. Metabolism of eicosanoids. Dalam: Parnham M,

Schroeder JM, editor. Fatty acids and inflammatory skin diseases. Edisi

ke-1. New York: Springer; 2000. H. 15-38.

36. Morris DH. Backgrounder on omega-3 fatty acids. In: Flax a heat and

nutrition primer. Flax Council of Canada, 3rdedition 2003: 22-33.

37. Simopoulos AP, Bazan NG (eds): Omega-3 Fatty Acids, the Brain and

Retina.World Rev Nutr Diet. Basel, Karger. 2009; 99: 1–16.

38. Maskrey BH, Megson IL, Rossi AG, Whitfield PD. Emerging importance

of omega-3 fatty acids in the innate immune respose: Molecular

mechanisms and lipidomic strategies for their analysis. Mo. Nutr. Food

Res. 2013;1-11.

39. Pilkington SM, Rhodes LE. Omega-3 fatty acids and skin. Dalam:

Krutmann J, Humbert P, editors. Nutrition for healthy skin. Edisi ke-1.

Berlin: Springer 2011:91-101.

40. Kochman K, Czauderna M. The necessity of adequate nutrition with diets

containing omega-3 and omega-6 fatty acids for proper brain development,

function and delayed aging: Review Journal of Animal and Feed Sciences.

2010;19:511–524.

41. Brash, A.R. Arachidonic acid as a bioactive molecule. J. Clin Invest

2001;107:1339-1345.

42. Simopolous AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio

and genetic variation: nutritional implications for chronic diseases.

Biomedicine & Phamacotherapy 2006; 60: 502-507.

43. Weylandt KH, Chiu CY, Gomolka B, Waechter SF. Omega-3 fatty acids

and their lipid mediators: towards an understanding of resolving and

protectin formation. Journal of Prostandings & other lipid mediators.

2012;97:73-82.
44. Haeggstrom, J.Z. and Funk, C.D. Lipoxygenase and leukotriene pathways:

biochemistry, biology, and roles in disease. Chem. Rev 2011;111:5866–

5898.

45. Yaqoob P. fatty acids and the immune system mechanisms underlying the

immunomodulatory effects of omega-3 PUFA. Proceeding of the nutrition

society 2010;69:311-315.

46. Shaikh SR, Edidin M. Polyunsaturated fatty acids, membrane

organization, T cells and antigen presentation. Am J Clin Nutr

2006;84:1277-89.

47. Westergaard M, Hennigsen J, Johansen C, Svendsen ML. Expression and

localization of peroxisome proliferator activated receptors and nuclear

factor in normal and lesional psoriatic skin. J Invest Dermatol 2003;1104-

1117.

48. Schmuth M, Jiang YJ, Dubrac S, Elias PM, Feingold KR. Peroxisome

proliferator-activated receptors and liver receptors in epidermal biology.

Journal of Lipid Research 2008;49:409-509.

49. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ.

Determinants of quality of life in patients with psoriasis: a study from the

US population. J Am Acad Dermatol 2004; 51: 704-8.

50. Tsai TF, Wang TS, Hung ST. Epidemiology and comorbidities of psoriasis

patients in a national database in Taiwan. J Dermatol Sci 2011; 63: 40-6.

51. Henseler T. Christophers E. Psoriasis of early and late onset:

characterization of two types of psoriasis vulgaris. J Am Acad Dermatl

1990; 13: 450-56.

52. Sommer DM, Jenisch SS, Suchan M, Christophers E, Weichental M.

Increased prevalence of the metabolic syndrome in patients with moderate

to severe psoriasis. Arch Dermatol Res 2007; 298: 321.

53. Naldi L, Parazzini F, Peli L, Chatenoud L, Cainelli T. Dietary factors and

the risk of psoriasis. Results of an Italian case control study. Br J Dermatol

1996; 134: 101-6.

54. Simopoulos AP. Omega-6/omega-3 essential fatty acid ratio and chronic

diseases. Food Reviews International 2004; 20: 77-90.

55. Simopoulus AP. Omega-3 fatty acids in inflammation and autoimmune

disease. J Am Coll of Nutr 2002; 21: 495-505.

56. Ailsa AW, Subodha SS, Marleen A, Nicholas JW, Kay TK. Dietary intake

and status of n-3 polyunsaturated fatty acids in a population of fish-eating

and non-fish-eating meat eaters, vegetarians, and vegans and the

precursor-product ratio of α-linolenic acid to long-chain n-3

polyunsaturated fatty acids: results from the EPIC-Norfolk cohort. Am J

Clin Nutr 2010; 92: 1040-51.

57. Naldi L, Addis A, Chimenti S, Giannetti A, Picardo M, Tomino C, et al.

Impact of body mass index and obesity and clinical response to systemic

treatment for psoriasis, evidence from the Psocane project. Dermatology

2008; 217: 365-75.

58. Simopoulus AP. An increase in the omega-6/ omega-3 fatty acid ratio

increases the risk for obesity. Nutrients 2016; 8: 1-17.

59. Tamas D, Kathy K. Sex specific differences in essential fatty acid

metabolism. Am J Clin Nutr 2011; 94: 4s-5s.

60. Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. Health

implications of high dietary omega-6 polyunsaturated fatty acids. Journal

of Nutrition and Metabolism 2012; 1-16.

61. Johnson M, Bradford C. Omega-3, Omega-6 and Omega-9 Fatty Acids:

Implications for Cardiovascular and Other Diseases. J. Glycomics

Lipidomics 2014; 4:1-4

62. Christophers E, Sterry W. Psoriasis. In Dermatology in General Medicine,

p.489–515. Fitzpatrick, AZ Eisen and K Wolff, editors. New York, NY:

McGraw Hill. 1993.

63. Ziboh V, Cohen K, Ellis C, Miller C, Hamilton T, Kragballe K et al.

Effects of dietary supplementation of fish oil on neutrophil and epidermal

fatty acids. Modulation of clinical course of psoriatic subjects. Archives of

Dermatology 1986; 122 : 1277-82.

64. Henneicke VZ, Mirowietz U, Farber L. Highly purified omega-3

polyunsaturated fatty acids for topical treatment of psoriasis. Results of a

double-blind, placebo-controlled multicentre study 1993; 129: 713-7.

65. Mayser P, Grimm H, Grimminger F. n-3 fatty acids in psoriasis. British

Journal of Nutrition 2002; 87: S77-S82.